Dbv Technologies S.A. Sponsored ADR (DBVT)
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA 
DBV Technologies (DBVT) Is a Great Choice for 'Trend' Investors, Here's Why
DBV Technologies (DBVT) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Here's Why Momentum in DBV Technologies (DBVT) Should Keep going
DBV Technologies (DBVT) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
DBV Technologies ADRs Rise After Up to $306.9M in New Financing
American depositary receipts of DBV Technologies gained after the company reported new financing of up to $306.9 million.
DBV Aligns With FDA On Accelerated Approval For Viaskin Peanut Patch In Younger Kids
On Wednesday, DBV Technologies SA DBVT reached a significant milestone with the FDA regarding its Viaskin Peanut patch for toddlers aged 1–3 years.
DBV Technologies S.A. (DBVT) Q2 2024 Earnings Call Transcript
DBV Technologies S.A. (NASDAQ:DBVT ) Q2 2024 Earnings Conference Call July 30, 2024 5:30 PM ET Company Participants Katie Matthews – Investor Relations Daniel Tassé – Chief Executive Officer Pharis Mohideen – Chief Medical Officer Virginie Boucinha – Chief Financial Officer Conference Call Participants Jon Wolleben – Citizens JMP Operator Welcome to the DBV Second Quarter Financial Results and Business Update Conference Call.
